Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J DeAngelo

Showing results (51-60 of 320) with videos related to

Pageof 32
Sort By:
Genes, Chromosomes & Cancer|July 12, 2008
Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemiaJennifer L Poitras, Paola Dal Cin, Jon C Aster, et al.
Clinical and Translational Science|August 20, 2020
Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaJoseph Chen, May Haughey, Erik Vandendries, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 8, 2014
Impact of timely switching from imatinib to a second-generation tyrosine kinase inhibitor after 12-month complete cytogenetic response failure: a chart review analysisDaniel J DeAngelo, Lei Chen, Annie Guerin, et al.
Blood Advances|September 2, 2021
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trialsAndrew Hantel, Marlise R Luskin, Jacqueline S Garcia, et al.
Leukemia Research|January 3, 2015
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromesDaniel A Roberts, Martha Wadleigh, Anne M McDonnell, et al.
Haematologica|March 4, 2021
Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021Tariq I Mughal, Bethan Psaila, Daniel J DeAngelo, et al.
American Journal of Hematology|August 30, 2008
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remissionRichard M Stone, Daniel J DeAngelo, Anna Janosova, et al.
Blood|July 7, 2005
Gefitinib induces myeloid differentiation of acute myeloid leukemiaKimberly Stegmaier, Steven M Corsello, Kenneth N Ross, et al.
Expert Opinion on Therapeutic Targets|January 12, 2011
Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancerMeng Wang, Bruno C Medeiros, Harry P Erba, et al.
American Journal of Hematology|February 29, 2008
Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locationsGregory A Abel, Daniel J DeAngelo, Jean M Connors, et al.
Pageof 32

Showing results (51-60 of 320) with videos related to

Sort By:
Pageof 32
Genes, Chromosomes & Cancer|July 12, 2008
Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemiaJennifer L Poitras, Paola Dal Cin, Jon C Aster, et al.
Clinical and Translational Science|August 20, 2020
Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaJoseph Chen, May Haughey, Erik Vandendries, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 8, 2014
Impact of timely switching from imatinib to a second-generation tyrosine kinase inhibitor after 12-month complete cytogenetic response failure: a chart review analysisDaniel J DeAngelo, Lei Chen, Annie Guerin, et al.
Blood Advances|September 2, 2021
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trialsAndrew Hantel, Marlise R Luskin, Jacqueline S Garcia, et al.
Leukemia Research|January 3, 2015
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromesDaniel A Roberts, Martha Wadleigh, Anne M McDonnell, et al.
Haematologica|March 4, 2021
Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021Tariq I Mughal, Bethan Psaila, Daniel J DeAngelo, et al.
American Journal of Hematology|August 30, 2008
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remissionRichard M Stone, Daniel J DeAngelo, Anna Janosova, et al.
Blood|July 7, 2005
Gefitinib induces myeloid differentiation of acute myeloid leukemiaKimberly Stegmaier, Steven M Corsello, Kenneth N Ross, et al.
Expert Opinion on Therapeutic Targets|January 12, 2011
Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancerMeng Wang, Bruno C Medeiros, Harry P Erba, et al.
American Journal of Hematology|February 29, 2008
Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locationsGregory A Abel, Daniel J DeAngelo, Jean M Connors, et al.
Pageof 32